Evidence map›Paper›PMID 34278739›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Cell Analysis from Dried Blood Spots: New Opportunities in Immunology, Hematology, and Infectious Diseases.

Ines Ait Belkacem, Noushine Mossadegh-Keller, Penelope Bourgoin, Isabelle Arnoux, Marie Loosveld, Pierre-Emmanuel Morange, Thibaut Markarian, Pierre Michelet, Jean Marc Busnel, Sandrine Roulland and 2 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation.Journal of acquired immune deficiency syndromes (1999) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Myeloid cells in COVID-19 microenvironment.Signal transduction and targeted therapy · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Ines Ait BelkacemDepartment of Research and Development, Beckman Coulter Life Sciences-Immunotech, 130 Avenue de Lattre de Tassigny, Marseille, 13009, France.ORCID 0000-0002-1383-1095
Noushine Mossadegh-KellerAix Marseille Université, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, 13009, France.
Penelope BourgoinDepartment of Research and Development, Beckman Coulter Life Sciences-Immunotech, 130 Avenue de Lattre de Tassigny, Marseille, 13009, France.
Isabelle ArnouxDepartment of Hematology Laboratory, Timone University Hospital, APHM, 264 Rue Saint-Pierre, Marseille, 13005, France.ORCID 0000-0003-4530-9944
Marie LoosveldDepartment of Hematology Laboratory, Timone University Hospital, APHM, 264 Rue Saint-Pierre, Marseille, 13005, France.ORCID 0000-0002-8372-4148
Pierre-Emmanuel MorangeDepartment of Hematology Laboratory, Timone University Hospital, APHM, 264 Rue Saint-Pierre, Marseille, 13005, France.ORCID 0000-0002-9065-722X
Thibaut MarkarianDepartment of Hematology Laboratory, Timone University Hospital, APHM, 264 Rue Saint-Pierre, Marseille, 13005, France.ORCID 0000-0002-5960-7240
Pierre MicheletAix Marseille Université, INSERM, INRAE, C2VN, 27 Boulevard Jean Moulin, Marseille, 13385, France.ORCID 0000-0003-1233-713X
Jean Marc BusnelDepartment of Research and Development, Beckman Coulter Life Sciences-Immunotech, 130 Avenue de Lattre de Tassigny, Marseille, 13009, France.ORCID 0000-0001-6651-2437
Sandrine RoullandAix Marseille Université, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, 13009, France.ORCID 0000-0003-2187-1959
Franck GallandAix Marseille Université, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, 13009, France.
Fabrice MalergueDepartment of Research and Development, Beckman Coulter Life Sciences-Immunotech, 130 Avenue de Lattre de Tassigny, Marseille, 13009, France.ORCID 0000-0003-1322-1390
Centre National de la Recherche Scientifique · FRGenoscience Pharma (France) · FRInserm · FRCentre d’Immunologie de Marseille-Luminy · FRHôpital de la Timone · FR

Funding

Association Nationale de la Recherche et de la Technologie N°2018/1212Centre d'Immunologie de Marseille-Luminy (CIML)Fondation ARC pour la Recherche sur le Cancer
6 · The paper itself

Abstract

Blood cell analysis is a major pillar of biomedical research and healthcare. These analyses are performed in central laboratories. Rapid shipment from collection site to the central laboratories is currently needed because cells and biomarkers degrade rapidly. The dried blood spot from a fingerstick allows the preservation of cellular molecules for months but entire cells are never recovered. Here leucocyte elution is optimized from dried blood spots. Flow cytometry and mRNA expression profiling are used to analyze the recovered cells. 50-70% of the leucocytes that are dried on a polyester solid support via elution after shaking the support with buffer are recovered. While red blood cells lyse upon drying, it is found that the majority of leucocytes are preserved. Leucocytes have an altered structure that is improved by adding fixative in the elution buffer. Leucocytes are permeabilized, allowing an easy staining of all cellular compartments. Common immunophenotyping and mRNAs are preserved. The ability of a new biomarker (CD169) to discriminate between patients with and without Severe Acute Respiratory Syndrome induced by Coronavirus 2 (SARS-CoV-2) infections is also preserved. Leucocytes from blood can be dried, shipped, and/or stored for at least 1 month, then recovered for a wide variety of analyses, potentially facilitating biomedical applications worldwide.

Indexed as

Antibodies, ViralBiomarkersBlood Specimen CollectionCell SeparationCommunicable DiseasesCOVID-19Diagnostic Tests, RoutineDried Blood Spot TestingErythrocytesFlow CytometryHematologyHumansImmunophenotypingLeukocytesRNA, MessengerSARS-CoV-2Antibodies, ViralBiomarkersRNA, Messengeranalysiscellsdried blood spots

Identifiers

PMID34278739
PMCPMC8456206
OpenAlexW3185767118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.